WCM-Q Course Enhances Population Health Research in Qatar
A workshop provided by the Institute for Population Health (IPH) of Weill Cornell Medicine-Qatar (WCM-Q) successfully trained 49 healthcare professionals in the... Read more.
Dallah Healthcare Acquires Eastern Province Hospitals
Dallah Healthcare continues to expand its healthcare services and boost investment growth with its new acquisition and subscription agreement with Ayyan Investment... Read more.
Qatar Charity Performs Heart Surgeries in Ghana Medical Camp
Qatar Charity (QC) has successfully completed 42 congenital heart surgeries for children at the University of Ghana Medical Centre (UGMC) during a week-long medical... Read more.
MedServe: NSIA’s Game-Changer for Nigerian Healthcare
Bauchi, Nigeria – In a significant move to enhance healthcare outcomes in Nigeria, NSIA Advanced Medical Services Limited (MedServe) flagged off the first phase... Read more.
KFSHRC Highlights Medical Education at AMEE 2024 Switzerland
King Faisal Specialist Hospital & Research Centre (KFSHRC) is further expanding its global footprint by participating in the 2024 International Association for... Read more.
Study: Targeted Anesthesia Delivery Improves Efficiency and Accuracy
GE HealthCare recently announced the publication of the MASTER trial results in the peer-reviewed journal Anesthesia and Analgesia, demonstrating the safety and... Read more.
Thermo Fisher Wins R&D 100 Awards, Market Disruptor Honor
WALTHAM, Mass- Thermo Fisher Scientific the world leader in serving science, has received three R&D 100 Awards for innovations that aid researchers’ and scientists’... Read more.
Ghana: EUAA Updates on Health and Medical Services
The EUAA recently published five topical reports on the healthcare situation in Ghana, which provide information on the prevalence of gastroenterology, hepatitis,... Read more.
Dubai Hosts More than 691,000 Medical Tourists in 2023
A recent report by the Dubai Health Authority (DHA) has highlighted remarkable growth in the health tourism sector in Dubai in 2023. This upsurge is evident in the... Read more.
Tirzepatide Cuts Type 2 Diabetes Risk by 94% in Adults with Pre-Diabetes and Obesity
INDIANAPOLIS- Eli Lilly and Company announced today positive topline results from the SURMOUNT-1 three-year study (176-week treatment period) evaluating the... Read more.
